Guggenheim on Celldex Therapeutics (CLDX): 'We continue to think today's stock reaction is overdone'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Nasdaq falls as Alphabet set for record loss amid AI spending woes
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
| CELLDEX THERAPEUTICS, Inc. (NASDAQ: CLDX) | Delayed: 29.51 -0.15 (0.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.66 | 52 Week High | $18.62 | |||
| Open | $29.79 | 52 Week Low | $2.85 | |||
| Day High | $30.39 | P/E | N/A | |||
| Day Low | $29.47 | EPS | $-1.02 | |||
| Volume | 475,052 | |||||
